ICU Eyewear Revenue and Competitors

Location

N/A

Total Funding

Consumer

Industry

Estimated Revenue & Valuation

  • ICU Eyewear's estimated annual revenue is currently $4.9M per year.(i)
  • ICU Eyewear's estimated revenue per employee is $175,700

Employee Data

  • ICU Eyewear has 28 Employees.(i)
  • ICU Eyewear grew their employee count by 0% last year.

ICU Eyewear's People

NameTitleEmail/Phone
1
VP Supply ChainReveal Email/Phone
2
Human Resources ManagerReveal Email/Phone
3
Senior Sales ExecutiveReveal Email/Phone
4
Customer ServiceReveal Email/Phone
5
Sales Team MemberReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M398%N/AN/A
#2
$0.1M20%N/AN/A
#3
$5.1M297%N/AN/A
#4
$10M5039%N/AN/A
#5
$21.8M8743%N/AN/A
#6
$20.1M8010%N/AN/A
#7
$7.2M363%N/AN/A
#8
$6.2M317%N/AN/A
#9
$9.2M46-4%N/AN/A
#10
$124.9M398-1%N/AN/A
Add Company

What Is ICU Eyewear?

ICU Eyewear is a leading designer and marketer of reading glasses, sunglasses and specialty eyewear. ICU's brands, which include ICU, Wink, Dr. Dean Edell, Fisherman Eyewear and Guideline Eyegear, are sold in approximately 15,000 locations throughout the drug, food, convenience and specialty retail channels. ICU's products emphasize fashion, style and quality and offer a wide range of alternatives to traditional reading glasses for every occasion. The company's brands have earned a reputation for high quality, innovative design and editorially acclaimed fashion in publications such as Vogue Magazine, O, The Oprah Magazine, The Today Show, Women's Wear Daily, Better Homes & Gardens, Body & Soul Magazine, “The Green Guide” by National Geographic, Giftware News, Gifts & Decorative Accessories and a myriad of consumer and industry online media outlets, blogs and print publications.

keywords:N/A

N/A

Total Funding

28

Number of Employees

$4.9M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.9M284%N/A
#2
$5.7M28-3%N/A
#3
$5.3M28-18%N/A
#4
$4.9M280%N/A
#5
$5.9M294%N/A